{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:08:25Z","timestamp":1778540905124,"version":"3.51.4"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Inova Fiocruz\/VPPCB","award":["VPPCB-008-FIO-18-2-49"],"award-info":[{"award-number":["VPPCB-008-FIO-18-2-49"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405520\/2018-2"],"award-info":[{"award-number":["405520\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["440015\/2018-9"],"award-info":[{"award-number":["440015\/2018-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301304\/2017-3"],"award-info":[{"award-number":["301304\/2017-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inova Fiocruz\/VPPCB","award":["VPPCB-007-FIO-18-2-57"],"award-info":[{"award-number":["VPPCB-007-FIO-18-2-57"]}]},{"name":"Inova Fiocruz\/VPPIS","award":["VPPIS-001-FIO-18-66"],"award-info":[{"award-number":["VPPIS-001-FIO-18-66"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["finance code 001"],"award-info":[{"award-number":["finance code 001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229630","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T14:58:48Z","timestamp":1589381928000},"page":"e0229630","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["A screening of the MMV Pathogen Box\u00ae reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4255-7486","authenticated-orcid":true,"given":"Rowena Alves","family":"Coelho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luna Sobrino","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Machado","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena Galdino","family":"Figueiredo-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio","family":"Brito-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Claudia Fernandes","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-3439","authenticated-orcid":true,"given":"Marcio L.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6639-6058","authenticated-orcid":true,"given":"Rodrigo","family":"Almeida-Paes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"pone.0229630.ref001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1590\/S0036-46652015000700009","article-title":"Chromoblastomycosis: a neglected tropical disease","volume":"57","author":"F Queiroz-Telles","year":"2015","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"pone.0229630.ref002","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"F Queiroz-Telles","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"pone.0229630.ref003","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3109\/13693780903503081","article-title":"Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data","volume":"48","author":"MJ Najafzadeh","year":"2010","journal-title":"Med Mycol"},{"key":"pone.0229630.ref004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13693780802527178","article-title":"Genetic diversity and species delimitation in the opportunistic genus Fonsecaea","volume":"47","author":"M Najafzadeh","year":"2009","journal-title":"Med Mycol"},{"key":"pone.0229630.ref005","doi-asserted-by":"crossref","first-page":"e0005102","DOI":"10.1371\/journal.pntd.0005102","article-title":"Molecular epidemiology of agents of human chromoblastomycosis in Brazil with the description of two novel species","volume":"10","author":"RR Gomes","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0229630.ref006","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/JCM.00637-15","article-title":"Fonsecaea pugnacius, a novel agent of disseminated Chromoblastomycosis","volume":"53","author":"CMPS de Azevedo","year":"2015","journal-title":"J Clin Microbiol"},{"key":"pone.0229630.ref007","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11046-013-9648-x","article-title":"Challenges in the therapy of chromoblastomycosis","volume":"175","author":"F Queiroz-Telles","year":"2013","journal-title":"Mycopathologia"},{"key":"pone.0229630.ref008","author":"J Cohen","year":"2017","journal-title":"Infectious diseases"},{"key":"pone.0229630.ref009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11046-012-9586-z","article-title":"Chromoblastomycosis in Mainland China: A systematic review on clinical characteristics","volume":"175","author":"S Lu","year":"2013","journal-title":"Mycopathologia"},{"key":"pone.0229630.ref010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13693780802468209","article-title":"Molecular diversity of Fonsecaea (Chaetothyriales) causing chromoblastomycosis in southern China","volume":"47","author":"L Xi","year":"2009","journal-title":"Med Mycol"},{"key":"pone.0229630.ref011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/13693786.2010.539631","article-title":"Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment","volume":"49","author":"F Queiroz-Telles","year":"2011","journal-title":"Med Mycol"},{"key":"pone.0229630.ref012","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clindermatol.2011.09.011","article-title":"Chromoblastomycosis","volume":"30","author":"E Torres-Guerrero","year":"2012","journal-title":"Clin Dermatol"},{"key":"pone.0229630.ref013","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1590\/abd1806-4841.20187321","article-title":"Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update","volume":"93","author":"AC de Brito","year":"2018","journal-title":"An Bras Dermatol"},{"key":"pone.0229630.ref014","doi-asserted-by":"crossref","first-page":"e0006675","DOI":"10.1371\/journal.pntd.0006675","article-title":"Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil","volume":"12","author":"RA Coelho","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0229630.ref015","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-67144-4_14","article-title":"New therapeutic uses for existing drugs","volume":"1031","author":"BA Austin","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"pone.0229630.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd.2018.92","article-title":"Overcoming the legal and regulatory barriers to drug repurposing","volume":"18","author":"A Breckenridge","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0229630.ref017","first-page":"61","article-title":"Screening the Pathogen Box for identification of Candida albicans biofilm inhibitors","author":"T Vila","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0229630.ref018","first-page":"2","article-title":"Discovery of a novel antifungal agent in the Pathogen Box","author":"FL Mayer","year":"2017","journal-title":"mSphere"},{"key":"pone.0229630.ref019","first-page":"61","article-title":"Screening the Medicines for Malaria Venture Pathogen Box across multiple pathogens reclassifies starting points for open-source drug discovery","author":"S Duffy","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0229630.ref020","doi-asserted-by":"crossref","first-page":"e0195595","DOI":"10.1371\/journal.pone.0195595","article-title":"Pathogen Box screening for hit identification against Mycobacterium abscessus","volume":"13","author":"J Jeong","year":"2018","journal-title":"PLOS ONE"},{"key":"pone.0229630.ref021","doi-asserted-by":"crossref","first-page":"e0006673","DOI":"10.1371\/journal.pntd.0006673","article-title":"Screening of the Pathogen Box for inhibitors with dual efficacy against Giardia lamblia and Cryptosporidium parvum","volume":"12","author":"KM Hennessey","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pone.0229630.ref022","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1039\/C8MD00319J","article-title":"Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discovery","volume":"9","author":"CGL Veale","year":"2018","journal-title":"MedChemComm"},{"key":"pone.0229630.ref023","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molbiopara.2018.05.001","article-title":"Screening of the MMV and GSK open access chemical boxes using a viability assay developed against the kinetoplastid Crithidia fasciculata","volume":"222","author":"W Kipandula","year":"2018","journal-title":"Mol Biochem Parasitol"},{"key":"pone.0229630.ref024","unstructured":"Arendrup MC, Meletiadis J, Mouton JW, Lagrou K, Petr Hamal, Guinea J, et al. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. EUCAST; 2017. Available: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Files\/EUCAST_E_Def_9_3_1_Mould_testing__definitive.pdf"},{"key":"pone.0229630.ref025","volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","author":"CLSI\u2014Clinical and Laboratory Standars Institute","year":"2008"},{"key":"pone.0229630.ref026","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1874285801105010096","article-title":"Inhibition of growth of highly resistant bacterial and fungal pathogens by a natural product","volume":"5","author":"RR Hafidh","year":"2011","journal-title":"Open Microbiol J"},{"key":"pone.0229630.ref027","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1128\/AAC.46.8.2708-2711.2002","article-title":"others. In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents","volume":"46","author":"E Dannaoui","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0229630.ref028","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"FC Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"pone.0229630.ref029","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2131\/jts.41.731","article-title":"Trifloxystrobin-induced mitophagy through mitochondrial damage in human skin keratinocytes","volume":"41","author":"Y Jang","year":"2016","journal-title":"J Toxicol Sci"},{"key":"pone.0229630.ref030","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jflm.2013.08.012","article-title":"Acute fatal poisoning with Tolfenpyrad","volume":"20","author":"W Hikiji","year":"2013","journal-title":"J Forensic Leg Med"},{"key":"pone.0229630.ref031","first-page":"5","article-title":"Repositionable compounds with antifungal activity against multidrug resistant Candida auris identified in the Medicines for Malaria Venture\u2019s Pathogen Box","author":"G Wall","year":"2019","journal-title":"J Fungi Basel Switz"},{"key":"pone.0229630.ref032","first-page":"167","article-title":"Auranofin therapy in rheumatoid arthritis","volume":"100","author":"GC Bernhard","year":"1982","journal-title":"J Lab Clin Med"},{"key":"pone.0229630.ref033","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/j.1875-9114.1983.tb03277.x","article-title":"Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin: an orally administered organic gold compound for the treatment of rheumatoid arthritis","volume":"3","author":"DE Furst","year":"1983","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"pone.0229630.ref034","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4155\/fmc.15.182","article-title":"Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin","volume":"8","author":"BB Fuchs","year":"2016","journal-title":"Future Med Chem"},{"key":"pone.0229630.ref035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fcimb.2017.00004","article-title":"Repurposing approach identifies auranofin with broad spectrum antifungal activity that targets Mia40-Erv1 pathway","volume":"7","author":"S Thangamani","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"pone.0229630.ref036","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/21505594.2016.1196301","article-title":"Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi","volume":"8","author":"NP Wiederhold","year":"2017","journal-title":"Virulence"},{"key":"pone.0229630.ref037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3114\/sim.2007.58.08","article-title":"Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species","volume":"58","author":"GS de Hoog","year":"2007","journal-title":"Stud Mycol"},{"key":"pone.0229630.ref038","first-page":"2013","article-title":"Amoebic dysentery","author":"C Marie","year":"2013","journal-title":"BMJ Clin Evid"},{"key":"pone.0229630.ref039","first-page":"273","article-title":"Antimicrobial activity of iodoquinol 1%-hydrocortisone acetate 2% gel against ciclopirox and clotrimazole","volume":"82","author":"BP Burnett","year":"2008","journal-title":"Cutis"},{"key":"pone.0229630.ref040","first-page":"21","article-title":"Synthesis, fungicidal activity and mode of action of 4-Phenyl-6-trifluoromethyl-2-aminopyrimidines against Botrytis cinerea","author":"C Liu","year":"2016","journal-title":"Mol Basel Switz"},{"key":"pone.0229630.ref041","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.11.027","article-title":"Novel aminopyrimidinyl benzimidazoles as potentially antimicrobial agents: Design, synthesis and biological evaluation","volume":"143","author":"H-B Liu","year":"2018","journal-title":"Eur J Med Chem"},{"key":"pone.0229630.ref042","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1517\/14728222.2015.1067685","article-title":"Bacterial, fungal and protozoan carbonic anhydrases as drug targets","volume":"19","author":"C Capasso","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"pone.0229630.ref043","first-page":"1104","article-title":"Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity","volume":"20","author":"M Kucerova-Chlupacova","year":"2015","journal-title":"Mol Basel Switz"},{"key":"pone.0229630.ref044","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1099\/jmm.0.000041","article-title":"Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole","volume":"64","author":"LP Borba-Santos","year":"2015","journal-title":"J Med Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T14:59:11Z","timestamp":1589381951000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229630"}},"subtitle":[],"editor":[{"given":"Kirsten","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229630","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.02.12.945378","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]}}}